Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Navitus Drug Trend Report: Keeping Costs Low for Plans and Members in an Era of Accelerating Inflation 30% of Navitus clients spent less in 2024 than in the previous year despite overall market spend growth, expanded GLP-1 RA use and rising specialty medication prices Madison, WI June 10, 2025 Navitus, the nations first transparent, pass-through pharmacy benefit manager (PBM), released its ninth annual Drug Trend Report today, revealing how commercial plan sponsors saved millions in prescription costs while maintaining high-quality member care
Careful attention to fluid intake is important, especially during the first weeks of treatment and during dose escalation
Transient jitteriness
17.8% reduction in collagen fragmentation in 4 weeks (NIH)
Accordingly, a PAR2-mutant mouse resistant to TMPRSS2 cleavage is protected from GIP upregulation and diet-induced obesity
US$ 29.83
US$ 25.41
US$ 26.83
US$ 24.47
US$ 24.12
US$ 24.79
